KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Stryker (SYK) Other Operating Expenses (2016 - 2026)

Stryker has reported Other Operating Expenses over the past 18 years, most recently at $180.0 million for Q1 2026.

  • Quarterly Other Operating Expenses fell 10.89% to $180.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $880.0 million through Mar 2026, down 46.54% year-over-year, with the annual reading at $902.0 million for FY2025, 43.62% down from the prior year.
  • Other Operating Expenses was $180.0 million for Q1 2026 at Stryker, down from $196.0 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $1.1 billion in Q4 2024 and troughed at $155.0 million in Q3 2022.
  • The 5-year median for Other Operating Expenses is $171.0 million (2024), against an average of $250.0 million.
  • Year-over-year, Other Operating Expenses soared 501.08% in 2024 and then crashed 82.37% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at $414.0 million in 2022, then plummeted by 55.31% to $185.0 million in 2023, then soared by 501.08% to $1.1 billion in 2024, then crashed by 82.37% to $196.0 million in 2025, then decreased by 8.16% to $180.0 million in 2026.
  • Per Business Quant, the three most recent readings for SYK's Other Operating Expenses are $180.0 million (Q1 2026), $196.0 million (Q4 2025), and $262.0 million (Q3 2025).